These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 12354792)
1. Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle - eye - brain disorders. Holzfeind PJ; Grewal PK; Reitsamer HA; Kechvar J; Lassmann H; Hoeger H; Hewitt JE; Bittner RE Hum Mol Genet; 2002 Oct; 11(21):2673-87. PubMed ID: 12354792 [TBL] [Abstract][Full Text] [Related]
2. The sarcolemma in the Large(myd) mouse. Reed PW; Mathews KD; Mills KA; Bloch RJ Muscle Nerve; 2004 Nov; 30(5):585-95. PubMed ID: 15389724 [TBL] [Abstract][Full Text] [Related]
3. Soleus muscle in glycosylation-deficient muscular dystrophy is protected from contraction-induced injury. Gumerson JD; Kabaeva ZT; Davis CS; Faulkner JA; Michele DE Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1430-40. PubMed ID: 20844247 [TBL] [Abstract][Full Text] [Related]
4. Glycosylation defects: a new mechanism for muscular dystrophy? Grewal PK; Hewitt JE Hum Mol Genet; 2003 Oct; 12 Spec No 2():R259-64. PubMed ID: 12925572 [TBL] [Abstract][Full Text] [Related]
5. Muscle-specific expression of LARGE restores neuromuscular transmission deficits in dystrophic LARGE(myd) mice. Gumerson JD; Davis CS; Kabaeva ZT; Hayes JM; Brooks SV; Michele DE Hum Mol Genet; 2013 Feb; 22(4):757-68. PubMed ID: 23222475 [TBL] [Abstract][Full Text] [Related]
6. The role of defective glycosylation in congenital muscular dystrophy. Schachter H; Vajsar J; Zhang W Glycoconj J; 2004; 20(5):291-300. PubMed ID: 15229394 [TBL] [Abstract][Full Text] [Related]
7. A rapid PCR method for genotyping the Large(myd) mouse, a model of glycosylation-deficient congenital muscular dystrophy. Browning CA; Grewal PK; Moore CJ; Hewitt JE Neuromuscul Disord; 2005 May; 15(5):331-5. PubMed ID: 15833424 [TBL] [Abstract][Full Text] [Related]
8. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029 [TBL] [Abstract][Full Text] [Related]
9. Defects in glycosylation impair satellite stem cell function and niche composition in the muscles of the dystrophic Large(myd) mouse. Ross J; Benn A; Jonuschies J; Boldrin L; Muntoni F; Hewitt JE; Brown SC; Morgan JE Stem Cells; 2012 Oct; 30(10):2330-41. PubMed ID: 22887880 [TBL] [Abstract][Full Text] [Related]
10. biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies. Gumlaw N; Sevigny LM; Zhao H; Luo Z; Bangari DS; Masterjohn E; Chen Y; McDonald B; Magnay M; Travaline T; Yoshida-Moriguchi T; Fan W; Reczek D; Stefano JE; Qiu H; Beil C; Lange C; Rao E; Lukason M; Barry E; Brondyk WH; Zhu Y; Cheng SH Mol Ther; 2020 Feb; 28(2):664-676. PubMed ID: 31843448 [TBL] [Abstract][Full Text] [Related]
11. Defective glycosylation in muscular dystrophy. Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008 [TBL] [Abstract][Full Text] [Related]
12. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies. Chan YM; Keramaris-Vrantsis E; Lidov HG; Norton JH; Zinchenko N; Gruber HE; Thresher R; Blake DJ; Ashar J; Rosenfeld J; Lu QL Hum Mol Genet; 2010 Oct; 19(20):3995-4006. PubMed ID: 20675713 [TBL] [Abstract][Full Text] [Related]
13. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558 [TBL] [Abstract][Full Text] [Related]
14. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Grewal PK; Holzfeind PJ; Bittner RE; Hewitt JE Nat Genet; 2001 Jun; 28(2):151-4. PubMed ID: 11381262 [TBL] [Abstract][Full Text] [Related]
16. Sarcolemma instability during mechanical activity in Largemyd cardiac myocytes with loss of dystroglycan extracellular matrix receptor function. Kabaeva Z; Meekhof KE; Michele DE Hum Mol Genet; 2011 Sep; 20(17):3346-55. PubMed ID: 21628317 [TBL] [Abstract][Full Text] [Related]
17. Abnormal Skeletal Muscle Regeneration plus Mild Alterations in Mature Fiber Type Specification in Fktn-Deficient Dystroglycanopathy Muscular Dystrophy Mice. Foltz SJ; Modi JN; Melick GA; Abousaud MI; Luan J; Fortunato MJ; Beedle AM PLoS One; 2016; 11(1):e0147049. PubMed ID: 26751696 [TBL] [Abstract][Full Text] [Related]
18. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy. Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172 [TBL] [Abstract][Full Text] [Related]
19. Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy. Grewal PK; Hewitt JE Biochim Biophys Acta; 2002 Dec; 1573(3):216-24. PubMed ID: 12417403 [TBL] [Abstract][Full Text] [Related]
20. Cib2 binds integrin alpha7Bbeta1D and is reduced in laminin alpha2 chain-deficient muscular dystrophy. Häger M; Bigotti MG; Meszaros R; Carmignac V; Holmberg J; Allamand V; Akerlund M; Kalamajski S; Brancaccio A; Mayer U; Durbeej M J Biol Chem; 2008 Sep; 283(36):24760-9. PubMed ID: 18611855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]